Storia in 3 fonti

Study Compares GLP-1 Drugs on Their Benefits, Harms

Quality-of-life effects still a major unknown, researchers say

Raccontata da

healio.com

hindustantimes.com

medpagetoday.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

medpagetoday.comStai leggendo22 g fa

Study Compares GLP-1 Drugs on Their Benefits, Harms

Quality-of-life effects still a major unknown, researchers say

originale

hindustantimes.com23 g fa

Weight loss, muscle mass, heart risk: Study decodes strengths & weaknesses of 19 GLP-1 drugs

Tirzepatide burns most fat and muscle; semaglutide cuts death, heart attack and kidney risk, and jury is out on whether they improve quality of life | India News

Leggi questa versione → originale

Timeline cronologica

mercoledì 8 luglio 2026·healio.com
GLP-1s may improve outcomes in patients with peripheral artery disease and diabetes
GLP-1s may prevent adverse outcomes in patients with peripheral artery disease and diabetes, according to data published in the Journal of the American Heart Association.…
giovedì 9 luglio 2026·hindustantimes.com
Gains clear, but no single GLP-1 or other weight loss drug wins on every count: Study
A comprehensive analysis of 19 obesity drugs reveals no single standout, with weight loss often accompanied by muscle loss and side effects.

Study Compares GLP-1 Drugs on Their Benefits, Harms

Weight loss, muscle mass, heart risk: Study decodes strengths & weaknesses of 19 GLP-1 drugs

Timeline cronologica

GLP-1s may improve outcomes in patients with peripheral artery disease and diabetes

Gains clear, but no single GLP-1 or other weight loss drug wins on every count: Study

GLP-1s may improve outcomes in patients with peripheral artery disease and diabetes

Weight loss, muscle mass, heart risk: Study decodes strengths & weaknesses of 19 GLP-1 drugs

Study Compares GLP-1 Drugs on Their Benefits, Harms